Cargando…
Bifidobacterium animalis ssp. lactis 420 Protects against Indomethacin-Induced Gastric Permeability in Rats
Gastrointestinal (GI) adverse effects such as erosion and increased permeability are common during the use of nonsteroidal anti-inflammatory drugs (NSAIDs). Our objective was to assess whether Bifidobacterium animalis ssp. lactis 420 protects against NSAID-induced GI side effects in a rat model. A t...
Autores principales: | Lyra, Anna, Saarinen, Markku, Putaala, Heli, Olli, Kaisa, Lahtinen, Sampo J., Ouwehand, Arthur C., Madetoja, Mari, Tiihonen, Kirsti |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3405648/ https://www.ncbi.nlm.nih.gov/pubmed/22848210 http://dx.doi.org/10.1155/2012/615051 |
Ejemplares similares
-
Bifidobacterium animalis subsp. lactis 420 for Metabolic Health: Review of the Research
por: Uusitupa, Henna-Maria, et al.
Publicado: (2020) -
Polydextrose with and without Bifidobacterium animalis ssp. lactis 420 drives the prevalence of Akkermansia and improves liver health in a multi-compartmental obesogenic mice study
por: Yde, Christian Clement, et al.
Publicado: (2021) -
Effects of Bifidobacterium animalis ssp. lactis 420 on gastrointestinal inflammation induced by a nonsteroidal anti‐inflammatory drug: A randomized, placebo‐controlled, double‐blind clinical trial
por: Mäkelä, Sanna M., et al.
Publicado: (2021) -
Bifidobacterium animalis ssp. Lactis 420 Mitigates Autoimmune Hepatitis Through Regulating Intestinal Barrier and Liver Immune Cells
por: Zhang, Hongxia, et al.
Publicado: (2020) -
The Effect of Delivery Matrix on Bifidobacterium animalis subsp. lactis HN019 Survival through In Vitro Human Digestion
por: Yeung, Nicolas, et al.
Publicado: (2023)